Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, P.O. Box: 143951374, Tehran, Iran.
Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, P.O. Box: 143951374, Tehran, Iran.
Acta Biomater. 2019 Dec;100:142-157. doi: 10.1016/j.actbio.2019.10.007. Epub 2019 Oct 4.
To improve the efficacy of transdermal drug delivery systems, the physical and chemical properties of drugs need to be optimized to better penetrate into the stratum corneum and to better diffuse into the epidermis and dermis layers. Accordingly, dual-biological function ionic liquids composed of active pharmaceutical ingredients were synthesized, comprising both analgesic and anti-inflammatory properties, by combining a cation derived from lidocaine and anions derived from hydrophobic nonsteroidal anti-inflammatory drugs. Active pharmaceutical ingredient ionic liquids (API-ILs) were characterized through nuclear magnetic resonance, cytotoxicity assay, and water solubility assay. All properties were compared with those of the original drugs. By converting the analgesic and anti-inflammatory drugs into dual-function API-ILs, their water solubility increased up to 470-fold, without affecting their cytotoxic profile. These API-ILs were incorporated into a bilayer wound dressing composed of a hydrophobic polyvinylidene fluoride (PVDF) membrane to act as a drug reservoir and a biocompatible hyaluronic acid (HA) layer. The prepared bilayer wound dressing was characterized in terms of mechanical properties, membrane drug uptake and drug release behavior, and application in transdermal delivery, demonstrating to have desirable mechanical properties and improved release of API-ILs. The assessment of anti-inflammatory activity through the inhibition of LPS-induced production of nitric oxide and prostaglandin E2 by macrophages revealed that the prepared membranes containing API-ILs are as effective as those with the original drugs. Cell adhesion of fibroblasts on membrane surfaces and cell viability assay confirmed improved the viability and adhesion of fibroblasts on PVDF/HA membranes. Finally, wound healing assay performed with fibroblasts showed that the bilayer membranes containing dual-function API-ILs are not detrimental to wound healing, while displaying increased and controlled drug delivery and dual therapeutic behavior. STATEMENT OF SIGNIFICANCE: This work shows the preparation and characterization of bilayer wound dressings comprising dual-biological function active pharmaceutical ingredients based on ionic liquids with improved and controlled drug release and dual therapeutic efficiency. By converting analgesic and anti-inflammatory drugs into ionic liquids, their water solubility increases up to 470-fold. The prepared bilayer wound dressing membranes have desirable mechanical properties and improved release of drugs. The prepared membranes comprising ionic liquids display anti-inflammatory activity as effective as those with the original drugs. Cell adhesion of fibroblasts on membrane surfaces and cell viability assays show improved viability and adhesion of fibroblasts on PVDF/HA membranes, being thus of high relevance as effective transdermal drug delivery systems.
为了提高透皮给药系统的疗效,需要优化药物的物理和化学性质,以更好地穿透角质层,并更好地扩散到表皮和真皮层。因此,合成了由活性药物成分组成的具有双重生物学功能的离子液体,这些离子液体将利多卡因衍生的阳离子和疏水性非甾体抗炎药物衍生的阴离子结合在一起,兼具镇痛和抗炎作用。通过核磁共振、细胞毒性测定和水溶性测定对活性药物成分离子液体(API-ILs)进行了表征。所有性质均与原药进行了比较。将镇痛和抗炎药物转化为双重功能的 API-ILs 后,其水溶性提高了 470 倍,而不影响其细胞毒性特征。将这些 API-ILs 掺入由疏水性聚偏二氟乙烯(PVDF)膜组成的双层伤口敷料中,作为药物储库和生物相容的透明质酸(HA)层。制备的双层伤口敷料在机械性能、膜药物摄取和药物释放行为以及经皮给药方面进行了表征,结果表明其具有理想的机械性能和改善的 API-ILs 释放。通过抑制巨噬细胞中 LPS 诱导的一氧化氮和前列腺素 E2 的产生来评估抗炎活性,结果表明,含有 API-ILs 的制备膜与含有原药的膜同样有效。成纤维细胞在膜表面的黏附以及细胞活力测定证实,PVDF/HA 膜上成纤维细胞的活力和黏附得到了改善。最后,用成纤维细胞进行的伤口愈合试验表明,含有双重功能 API-ILs 的双层膜不会对伤口愈合造成损害,同时表现出增加和控制药物释放以及双重治疗作用。
声明的意义:本工作展示了基于离子液体的具有双重生物学功能的活性药物成分的双层伤口敷料的制备和表征,该敷料具有改善和控制药物释放以及双重治疗效率。通过将镇痛和抗炎药物转化为离子液体,其水溶性提高了 470 倍。所制备的双层伤口敷料膜具有理想的机械性能和改善的药物释放。由离子液体组成的制备膜显示出与原药一样有效的抗炎活性。成纤维细胞在膜表面的黏附以及细胞活力测定表明,PVDF/HA 膜上成纤维细胞的活力和黏附得到了改善,因此作为有效的经皮药物传递系统具有重要意义。
J Control Release. 2021-10-10
Colloids Surf B Biointerfaces. 2015-4-20
Int J Pharm. 2012-10-30
Acta Biomater. 2019-5-13
ACS Mater Au. 2024-11-28
Polymers (Basel). 2024-8-26
Polymers (Basel). 2021-6-26
Int J Mol Sci. 2020-11-5